AbbVie, Worcester, MA
AbbVie is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 29,000 people worldwide and markets medicines in more than 170 countries.
Post-doctoral Fellow/Immunology Discovery; lead the development of a large animal model of Inflammatory Bowel Disease; optimize applications of pre-clinical imaging technologies, invasive and non-invasive, in these models. Work with cross-disciplinary teams over 3 years to increase the efficiency of screening candidate drugs for IBD, resulting in the development of a nascent translatable model of IBD that accurately screens and monitors for colonic mucosal healing and for candidate drug bio-distribution.
For further information on the company, portfolio and commitments, please visit www.abbvie.com
At AbbVie, we have the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.